Skip to content

Clinical trials

Endometrial Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: Norway Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20042
20051
20091
20121
20131
20151
20162
20191
20201
20213
20222
20232
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting11
Active, not recruiting3
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Gynecologic Oncology Group3
Nordic Society of Gynaecological Oncology - Clinical Trials Unit3
AEterna Zentaris1
AstraZeneca1
BioNTech SE1
Canadian Cancer Trials Group1
Daiichi Sankyo1
Eikon Therapeutics1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms29
Uterine Cervical Neoplasms4
Neoplasm Metastasis3
Ovarian Neoplasms3
Neoplasms2
Alzheimer Disease1
Anus Neoplasms1
Basal Cell Carcinoma1
Breast Neoplasms1
Carcinoma, Endometrioid1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.